Henrike Veith

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Dimitrios Anastasiou, Yimin Yu, William J. Israelsen et al. · Nature Chemical Biology · 2012 · 825 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +15

Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries

Henrike Veith, Noel Southall, Ruili Huang et al. · Nature Biotechnology · 2009 · 219 citations · Full text

Medicine, Biochemistry, Pharmacology +16

Evaluation of Substituted <i>N</i>,<i>N</i>′-Diarylsulfonamides as Activators of the Tumor Cell Specific M2 Isoform of Pyruvate Kinase

Matthew B. Boxer, Jian‐kang Jiang, Matthew G. Vander Heiden et al. · Journal of Medicinal Chemistry · 2009 · 164 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase

Jian‐kang Jiang, Matthew B. Boxer, Matthew G. Vander Heiden et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 134 citations

Medicine, Cancer Biology, Pharmacology +4

Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology

Jennifer Dao, Robert J. Kurzeja, José M. Morachis et al. · Analytical Biochemistry · 2008 · 71 citations

Life Sciences, Biochemistry, Pharmacology +12